Close Menu

NEW YORK – Akers Biosciences on Monday effected a 1-for-24 reverse stock split of its outstanding common stock.

The Thorofare, New Jersey-based rapid screening and testing products provider had announced the reverse stock split on Friday.

In May, it was notified by the Nasdaq that it's stock was at risk of being delisted after its share had closed below the minimum $1 per share requirement for the past 30 days.

During Monday morning trading, shares of Akers were up to $7.12 per share after closing on Friday at $.29 per share.   

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.